Xenetic Biosciences Inc Capital Reinvestment Ratio

Latest as of December 2017: 0.00x

Xenetic Biosciences Inc capital reinvestment ratio. Xenetic Biosciences Inc (XBIO) has a Capital Reinvestment Ratio of 0.00x as of December 2017, meaning it reinvests 0% of its operating cash flow ($4.84 Million) in capital expenditures ($9.00K). Check Xenetic Biosciences Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$4.84 Million

USD

Capital Expenditures

$9.00K

USD

Data as of

Dec 2017

Most recent filing

Capital Reinvestment Ratio of Xenetic Biosciences Inc (2017–2017)

Capital reinvestment ratio of Xenetic Biosciences Inc from 2017 to 2017. This chart tracks Xenetic Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore XBIO net assets growth trend to track the company's year-over-year net asset growth rate.

Xenetic Biosciences Inc Capital Reinvestment Ratio by Year (2017–2017)

Xenetic Biosciences Inc capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see XBIO cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2017	0.01x	$1.49 Million	$9.26K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow